GSTP1 and prostate cancer: Due to the general problem to obtain prostate cancer tissue samples before and after hormonal therapy even in cooperation with a specialized center of uropathology (B.H) the number of specimens analyzed in our study admittedly is very small and the results therefore only allow to conclude that androgen ablation therapy appears to influence GSTP1 HM.